Home ⟩ Insights

Insights

rescheduling

4 min read • June 1, 2026

Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort

5 min read • May 27, 2026

EXCLUSIVE: Advocates Push To Shape DEA’s Marijuana Rescheduling Hearing on June 29

2 min read • May 18, 2026

Congress Pushes To Let VA Doctors Recommend Marijuana In Legal States

4 min read • May 15, 2026

DEA Says Registration Tools Are ‘Coming Soon,’ but Growers and Processors Are Already Applying

4 min read • May 12, 2026

Could Medical Cannabis Finally Cross State Lines? Attorneys Break Down Schedule III’s Biggest Legal Question

5 min read • May 9, 2026

DEA Registration, 280E Relief, and State Rules Top Concerns After Rescheduling Order

irwin simon ceo tilray brands cannabis canada brewdog marijuana medical

5 min read • May 8, 2026

Tilray CEO Says Schedule III Marks A Turning Point For U.S. Medical Cannabis

idaho cannabis law regulation marijuana medical bill legalization

3 min read • May 6, 2026

Federal Tax Guidance for State-Licensed Medical Cannabis Companies Is Coming, Treasury Says

4 min read • May 6, 2026

Exclusive: California Rolls Out New Guidance to Help Cannabis Businesses Prepare for Federal Rescheduling

cannabis investors rescheduling marijuana

4 min read • May 5, 2026

DEA Registration Window Opens: What Cannabis Operators and Investors Must Do Next

cannabis marijuana healthcare

3 min read • May 3, 2026

Lawmakers Push to Block Cannabis Rescheduling, Hemp THC Ban Looms Ahead of November 12 Cutoff

5 min read • May 2, 2026

Industry Attorneys Weigh In as Federal Cannabis Rescheduling Heads to June 29 Hearing

Latest Headlines

7 min read • September 10, 2026

Virginia’s Cannabis Lottery Opens the Market, Capital Determines Who Reaches Opening Day

3 min read • September 10, 2026

Cannabis Operators Keep Schedule III Tax Relief but Lose a Seat in Court

6 min read • September 10, 2026

How a Veteran-Led Cannabis Company Grew 2,342% to Make the Inc. 5000 Twice

5 min read • September 9, 2026

Cannabis Companies Face 15% Loan Rates While 68.1% of Surveyed Hemp Businesses Expect Closure

2 min read • September 9, 2026

Curaleaf Defends Aurora Cannabis Takeover Offer, Challenges Board’s Objections

5 min read • September 8, 2026

How Canopy Growth Is Expanding Beyond Flower in Australia’s 81-Tonne Cannabis Import Market

6 min read • September 8, 2026

Why Exporting Cannabis to Europe Is Harder Than It Looks: Organigram on EU-GMP, Testing and Supply

10 min read • September 7, 2026

Britain Is Finally Ready to Authorize CBD Foods. Europe Could Rewrite the Rules Again

6 min read • September 7, 2026

How EDUN Grew Vape Sales 519% in Colorado’s Shrinking Cannabis Market

3 min read • September 4, 2026

Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation

7 min read • September 4, 2026

Cannabis M&A Enters Its Distressed-Asset Era: What Cresco’s $50 Million Pennsylvania Deal Must Deliver

2 min read • September 3, 2026

Aurora CEO On Curaleaf Takeover: ‘It’s Clear Why They Want It,’ But Offer Isn’t Adequate

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.